Apply to trial NCT06532084

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 2Drug trial

Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen

This is a single-center randomized open-label phase II clinical trial to compare relapse prophylaxis with sorafenib and observation after graft-versus-host disease prophylaxis with post-transplantation bendamustine and cyclophosphamide in high-risk myeloid malignancies. This is an intention to treat study, where randomization is performed at first documentation of CR after engraftment.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening